Analysis of the Presence and Levels of IgG Antibodies Directed against the S1 Protein Receptor Binding Domain and the N Protein of SARS-CoV-2 in Patients with Multiple Sclerosis Treated with Immunomodulatory Therapies

Analysis of the Presence and Levels of IgG Antibodies Directed against the S1 Protein Receptor Binding Domain and the N Protein of SARS-CoV-2 in Patients with Multiple Sclerosis Treated with Immunomodulatory Therapies

The coronavirus 2019 disease (COVID-19) course and serological statuses of patients with relapsing–remitting multiple sclerosis (RRMS), treated with disease-modifying therapies (DMTs) are generally parallel that of the general population. Over the pandemic’s course, however, a notable increase in th...

Full description

Bibliographic Details
Main Authors: Joanna Kulikowska, Katarzyna Kapica-Topczewska, Monika Gudowska-Sawczuk, Agnieszka Kulczyńska-Przybik, Marcin Bazylewicz, Anna Mirończuk, Agata Czarnowska, Waldemar Brola, Barbara Mroczko, Jan Kochanowicz, Alina Kułakowska
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Vaccines
Subjects:
COVID-19
SARS-CoV-2
receptor binding domain
spike protein
nucleocapsid protein
multiple sclerosis
Online Access:https://www.mdpi.com/2076-393X/12/3/255

Internet

https://www.mdpi.com/2076-393X/12/3/255

Similar Items